Title
Protein Secondary Structure Prediction: Helical transmembrane region prediction using Adaptive NeuroFuzzy Inference System,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
Over last many years, various computational models have been applied for solving various biological problems. Various transmembrane region predictors have been developed for prediction of secondary structure of proteins with varying levels of accuracy. This book provides Adaptive NeuroFuzzy Inference System (ANFIS) based model for predicting helical transmembrane region by acquiring the structural information of target protein directly from its sequence data. Also, a Fuzzy Inference System was developed using the same test set for comparing the performance of ANFIS model. The best configuration of ANFIS model with RMSE and accuracy as 40.92% and 76.76%, respectively, seems to outperform the fuzzy model, which attained RMSE and accuracy as 54.45% and 70.37%, respectively. The success of this approach suggests that it can find potential applications in other sequencebased analysis problems. The model decsribed in this book will be useful to bioinformaticians developing new and challenging models for solving different biological problems.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.